News Archive

Date: 02/10/2012
Cancer research depends on people volunteering to participate in clinical studies.
Date: 02/08/2012
Chat participants can ask questions of U-M lung cancer doctorWritten by Justin Harris; contact at 734-764-2220 or
Date: 02/06/2012
Understanding how cancer cells survive is a primary focus of investigation in Elizabeth R. Lawlor's researchWritten by Margarita Wagerson; contact at 734-764-2220.
Date: 01/31/2012
A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers.
Date: 01/25/2012
Researchers at the University of Michigan, led by Max Wicha, M.D., have found that Avastin, Sutent increase breast cancer stem cells. This could explain the limited success of anti-angiogenesis treatments in breast cancer.
Date: 01/20/2012
University of Michigan Health System is first U.S. academic site to put GE's Veo, which greatly reduces the amount of radiation exposure and therefore, cancer risk, into clinical use.
Date: 01/17/2012
Pavan Reddy, M.D., associate professor of hematology/oncology at the U-M Medical School, was the senior researcher who discovered alpha-1-antitrypsin -- a natural enzyme -- reduces intense inflammation after bone marrow transplant.
Date: 01/16/2012
Researchers at the University of Michigan have found that matted lymph nodes appear to signal increased chance of oropharyngeal cancer spreading to other parts of the body.
Date: 01/13/2012
In a new study, a program known as Spatially Invariant Vector Quantization (SIVQ) separated a malignancy from background tissue in digital slides of a type of bladder cancer whose features can vary widely and presents diagnostic challenges even for experts.
Date: 01/12/2012
Kathleen A. Cooney, M.D. of the University of Michigan Comprehensive Cancer Center, led this research effort which may may provide clues on prostate cancer development and who may need earlier screening.